|
Leader
|
|
|
00000cz aa2200037n 45 0 |
|
001
|
|
|
BNE|XX4779476
(VIAF cluster)
(Authority/Source Record)
|
|
005
|
|
|
20090804 |
|
008
|
|
|
090403n|#azznnaabn |a aaa || |
|
003
|
|
|
BNE |
|
035
|
|
|
‡a
(BNE)XX4779476
|
|
010
|
|
|
‡a
XX4779476
|
|
040
|
|
|
‡a
SpMaBN
‡b
spa
‡c
SpMaBN
‡e
rdc
‡f
embne
|
|
100
|
1 |
|
‡a
Alba Conejo, Emilio
|
|
400
|
1 |
|
‡a
Alba, Emilio
|
|
670
|
|
|
‡a
Tratado de oncología, 2009-
‡b
port. (co-editores, Emilio Alba Conejo... [et al.])
|
|
670
|
|
|
‡a
Estrategias para maximizar la eficacia de trastuzumab en pacientes con cardiotoxicidad asociada, 2009
‡b
p. 3 (autores, Emilio Alba; Servicio de Oncología, Hospital Univ. Virgen de la Víctoria, Málaga... [et al.])
|
|
901
|
|
|
‡a
978849262016
‡9
1
|
|
910
|
|
|
‡a
tratadodeoncologia
‡A
Tratado de oncología
‡l
spa
‡9
1
|
|
910
|
|
|
‡a
cambiandoestandareseneltratamientodelcancer
‡A
Cambiando estándares en el tratamiento del cáncer
‡l
spa
‡9
1
|
|
919
|
|
|
‡a
estrategiasparamaximizarlaeficaciadetrastuzumabenpacientesconcardiotoxicidadasociada
‡A
Estrategias para maximizar la eficacia de trastuzumab en pacientes con cardiotoxicidad asociada, 2009
‡9
1
|
|
920
|
|
|
‡a
978-8492
‡9
1
|
|
921
|
|
|
‡a
permanyer
‡b
Permanyer
‡9
1
|
|
921
|
|
|
‡a
aran
‡b
Arán
‡9
1
|
|
922
|
|
|
‡a
‡b
es
‡9
1
|
|
922
|
|
|
‡a
sp
‡b
es
‡9
1
|
|
940
|
|
|
‡a
spa
‡9
3
|
|
943
|
|
|
‡a
200x
‡9
3
|
|
944
|
|
|
‡a
am
‡9
1
|
|
944
|
|
|
‡a
gm
‡9
1
|
|
950
|
|
|
‡a
cortes funes hernan
‡A
Cortés Funes, Hernán
‡9
1
|
|
950
|
|
|
‡a
colomer bosch ramon
‡A
Colomer Bosch, Ramón
‡9
1
|
|
950
|
|
|
‡a
munoz montserrat munoz mateu
‡A
Muñoz, Montserrat
‡q
Muñoz Mateu
‡9
1
|
|
950
|
|
|
‡a
rivera herrero fernando
‡A
Rivera Herrero, Fernando
‡d
1964-
‡9
1
|
|
950
|
|
|
‡a
garcia campelo rosario
‡A
García-Campelo, Rosario
‡9
1
|
|
950
|
|
|
‡a
massuti sureda b
‡A
Massuti Sureda, B.
‡9
1
|
|
950
|
|
|
‡a
anton antonio anton torres
‡A
Antón, Antonio
‡q
Antón Torres
‡9
1
|
|
950
|
|
|
‡a
germa lluch j r
‡A
Germá Lluch, J. R.
‡9
1
|
|
950
|
|
|
‡a
maroto jose pablo
‡A
Maroto, José Pablo
‡9
1
|
|
950
|
|
|
‡a
tabernero caturla josep
‡A
Tabernero Caturla, Josep
‡9
1
|
|
951
|
|
|
‡a
grupo aran de comunicacion
‡A
Grupo Arán de Comunicación
‡9
1
|
|
960
|
|
|
‡a
sociedad espanola de oncologia medica
‡A
Sociedad Española de Oncología Médica
‡9
1
|
|
996
|
|
|
‡2
WKP|Q57023242
|
|
996
|
|
|
‡2
ISNI|0000000000179785
|
|
996
|
|
|
‡2
ISNI|0000000052470224
|
|
996
|
|
|
‡2
WKP|Q76882366
|
|
996
|
|
|
‡2
PLWABN|9810687355505606
|
|
996
|
|
|
‡2
SUDOC|163975329
|
|
996
|
|
|
‡2
DNB|1201521432
|
|
996
|
|
|
‡2
ISNI|0000000112860575
|
|
996
|
|
|
‡2
WKP|Q67215723
|
|
996
|
|
|
‡2
NUKAT|n 99710163
|
|
996
|
|
|
‡2
LIH|LNB:BF_g__u_;=B0
|
|
996
|
|
|
‡2
LC|nr2002010746
|
|
996
|
|
|
‡2
NDL|00902824
|
|
996
|
|
|
‡2
BNF|12353194
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
999
|
|
|
‡2
BNEBIB|a4847871
|
|
999
|
|
|
‡2
BNEBIB|a4458565
|
